Pharmacometrics modeling coupled with machine learning for early prediction of survival following atezolizumab monotherapy in non-small cell lung cancer - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly
Poster Communications Year : 2022

Pharmacometrics modeling coupled with machine learning for early prediction of survival following atezolizumab monotherapy in non-small cell lung cancer

Fichier principal
Vignette du fichier
2022_wcop_dlight_V2_CJ_SB.pdf (3.2 Mo) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-03935786 , version 1 (12-01-2023)

Identifiers

  • HAL Id : hal-03935786 , version 1

Cite

Sébastien Benzekry, Mélanie Karlsen, Abdessamad Elkaoutari, Suresh Vatakuti, Petter Curle, et al.. Pharmacometrics modeling coupled with machine learning for early prediction of survival following atezolizumab monotherapy in non-small cell lung cancer. compsyscan22 : A complex systems approach to cancer understanding, Oct 2022, Lyon, France. ⟨hal-03935786⟩
46 View
22 Download

Share

Gmail Mastodon Facebook X LinkedIn More